Adlouni A, el Messal M, Ghalim N, Saïle R
Département de Biologie, Faculté des Sciences Ben M'sik, Casablanca, Morocco.
Int J Clin Lab Res. 1997;27(4):247-52. doi: 10.1007/BF02912466.
We investigated for the first time in the Moroccan population the relationship between lipoprotein particles and the progression of coronary atherosclerosis. Plasma lipid variables, including total cholesterol, triglycerides, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, apolipoproteins AI and B, Lp AI, Lp AI: AII, and Lp(a) were measured in 40 Moroccan adults who suffered a verified myocardial infarction before the age of 50 years. The results were compared with a healthy control group. Plasma total cholesterol, triglyceride, and Lp AI: AII levels of patients did not differ significantly from control subjects. Patients had lower plasma high-density lipoprotein-cholesterol (P < 0.05), apo AI (P < 0.05), and Lp AI (P < 0.001) than control subjects, suggesting that the cholesterol reverse transport system is altered in patients with previous myocardial infarction. However, patients had higher plasma low-density lipoprotein-cholesterol (P < 0.001), apo B (P < 0.001), and Lp(a) (P < 0.001). In all patients the best predictor of cardiovascular risk was the independent risk factor Lp(a) plasma level, and the Lp AI plasma level. In this study, the increased coronary atherosclerosis risk with elevated plasma levels of apo B and Lp(a), and with reduced Lp AI, was substantially modified by smoking habits, but not by family history of myocardial infarction.
我们首次在摩洛哥人群中研究了脂蛋白颗粒与冠状动脉粥样硬化进展之间的关系。对40名在50岁之前发生过经证实的心肌梗死的摩洛哥成年人测量了血浆脂质变量,包括总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、载脂蛋白AI和B、Lp AI、Lp AI:AII以及Lp(a)。将结果与健康对照组进行比较。患者的血浆总胆固醇、甘油三酯和Lp AI:AII水平与对照组无显著差异。患者的血浆高密度脂蛋白胆固醇(P<0.05)、载脂蛋白AI(P<0.05)和Lp AI(P<0.001)低于对照组,这表明既往有心肌梗死的患者胆固醇逆向转运系统发生了改变。然而,患者的血浆低密度脂蛋白胆固醇(P<0.001)、载脂蛋白B(P<0.001)和Lp(a)(P<0.001)较高。在所有患者中,心血管风险的最佳预测指标是独立危险因素Lp(a)血浆水平和Lp AI血浆水平。在本研究中,血浆载脂蛋白B和Lp(a)水平升高以及Lp AI降低导致的冠状动脉粥样硬化风险增加,在很大程度上受到吸烟习惯的影响,但不受心肌梗死家族史的影响。